SARS-CoV-2 targets glial cells in human cortical organoids
Source McMahon et al. ยท <UNKNOWN>
Abstract
This protocol generates human cortical organoids from H9 embryonic stem cells using dual SMAD inhibition and characterizes SARS-CoV-2 infection patterns, particularly in glial cells, using immunofluorescence and molecular analysis. The method enables investigation of viral tropism and cellular responses in a 3D human brain tissue model.
Protocol overview
25 steps across 6 phases
- 1 H9 ESC Culture to Confluence
- 2 Dissociation to Single Cells
- 3 Transfer to Ultralow-Attachment Plates
- 4 Medium Replacement at Day 6
- 5 EGF and FGF-2 Supplementation (Days 6โ24)
- 6 Switch to BDNF and NT3 (Day 24โ43)
- 7 Unsupplemented Medium (Day 43+)
- 8 Vero E6 Cell Culturing
- 9 P5 Virus Generation from P4
- 10 P6 Working Stock Generation from P5
- 11 Virus Inactivation with TRIzol
- 12 RNA Extraction Using Liquid Handler
- 13 RNA Quantification
- 14 RT-qPCR Setup for Genomic RNA Quantification
- 15 Standard Curve and GE Calculations
- 16 Subgenomic RNA qPCR (E Region/Envelope)
- 17 Organoid Fixation
- 18 Cryoprotection in Sucrose
- 19 OCT Embedding and Cryosectioning
- 20 Blocking and Permeabilization
- 21 Primary Antibody Incubation
- 22 Secondary Antibody Incubation
- 23 Streptavidin Incubation
- 24 TBS Washes
- 25 Confocal Microscopy Imaging
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in McMahon et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol